Com­mon can­cer drug man­u­fac­tur­er warned by the FDA over da­ta in In­dia

Wracked with qual­i­ty ques­tion marks that have caused ma­jor short­ages of com­mon can­cer drugs, In­dia-based gener­ic drug man­u­fac­tur­er In­tas Phar­ma­ceu­ti­cals has been hand­ed a warn­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER